Sign Up to like & get
recommendations!
1
Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.4_suppl.50
Abstract: 50Background: Although immune checkpoint inhibitors have demonstrated promising results in melanoma and lung cancer, their effects on gastrointestinal cancer are still under investigation. Understand the prognostic effect of PDL1 expression, infiltration by CD8+ and CD3+…
read more here.
Keywords:
analysis pdl1;
gastric cancer;
pdl1 expression;
infiltration ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.6_suppl.454
Abstract: 454Background: Identification of biomarkers predictive of response to ICI could help guide treatment (tx) decisions. We assessed the correlation between PD1/PDL1 expression in key immunomodulatory subsets (myeloid-derived suppressor cells [MDSC]; CD8+ T cells) and tx…
read more here.
Keywords:
response;
pd1 pdl1;
pdl1 expression;
mdsc ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Cancers"
DOI: 10.3390/cancers13194782
Abstract: Simple Summary Tumors use immunosuppressive signals to evade detection by the immune system. While recurrent and metastatic head and neck squamous cell carcinoma has historically carried a poor prognosis, therapies targeting the immunosuppressive PD1:PDL1 axis…
read more here.
Keywords:
toll like;
tlr2;
pdl1 expression;
hnscc ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Neurology India"
DOI: 10.4103/0028-3886.325352
Abstract: Background: Gliomas are aggressive tumors with limited treatment options. Immunotherapy targets are under evaluation as new therapeutic targets in gliomas. Aims and Objectives: The aims of the study were to analyze expression of PDL1 in…
read more here.
Keywords:
gliomas;
pdl1 expression;
study;
programmed death ... See more keywords